G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression

Nature Communications

Volumn 7, Issue , 2016, Pages

  Zhang, Xi ^a   Peng, Danni ^a   Xi, Yuanxin ^b   Yuan, Chao ^a   Sagum, Cari A ^a   Klein, Brianna J ^c   Tanaka, Kaori ^a   Wen, Hong ^a   Kutateladze, Tatiana G ^c   Li, Wei ^b   Bedford, Mark T ^a,d   Shi, Xiaobing ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HISTONE ACETYLTRANSFERASE; HISTONE H4; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE 2; PROTEIN MOF; PROTEIN PHF20; UNCLASSIFIED DRUG; EHMT2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN; HISTOCOMPATIBILITY ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; KAT8 PROTEIN, HUMAN; NCOA2 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR 2; PHF20 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

CANCER; CELLS AND CELL COMPONENTS; CYTOGENETICS; ENZYME; ENZYME ACTIVITY; GENE EXPRESSION; METHYLATION; ORGANIC COMPOUND;

ARTICLE; BREAST CANCER CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METHYLATION; ACETYLATION; BREAST TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; IMMUNOPRECIPITATION; MCF-7 CELL LINE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACETYLATION; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS; HISTONE ACETYLTRANSFERASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOPRECIPITATION; IN VITRO TECHNIQUES; MAGNETIC RESONANCE SPECTROSCOPY; MCF-7 CELLS; NUCLEAR RECEPTOR COACTIVATOR 2; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84960510627     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10810     Document Type: Article

References (74)

1. Berger, S. L. The complex language of chromatin regulation during transcription. Nature 447, 407-412 (2007
2. Zhang, X., Wen, H., & Shi, X. Lysine methylation: beyond histones. Acta Biochim. Biophys. Sin. (Shanghai). 44, 14-27 (2012
3. Tsai, M. J., & O?Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486 (1994
4. Xu, L., Glass, C. K., & Rosenfeld, M. G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147 (1999
5. McKenna, N. J., & O?Malley, B. W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474 (2002
6. Kim, M. Y., Woo, E. M., Chong, Y. T., Homenko, D. R., & Kraus, W. L. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 20, 1479-1493 (2006
7. Wang, C. et al. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J. Biol. Chem. 276, 18375-18383 (2001
8. Le Romancer, M. et al. Cracking the estrogen receptor?s posttranslational code in breast tumors. Endocr. Rev. 32, 597-622 (2011
9. Subramanian, K. et al. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol. Cell 30, 336-347 (2008
10. Le Romancer, M. et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol. Cell 31, 212-221 (2008
11. Zhang, X. et al. Regulation of estrogen receptor alpha by histone methyltransferase SMYD2-mediated protein methylation. Proc. Natl Acad. Sci. USA 110, 17284-17289 (2013
12. Tachibana, M., Sugimoto, K., Fukushima, T., & Shinkai, Y. Set domaincontaining protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317 (2001
13. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M., & Nakatani, Y A complex with chromatin modifiers that occupies E2F-And Myc-responsive genes in G(0) cells. Science 296, 1132-1136 (2002
14. Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002
15. Chen, M. W. et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 70, 7830-7840 (2010
16. Lee, D. Y., Northrop, J. P., Kuo, M. H., & Stallcup, M. R. Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J. Biol. Chem. 281, 8476-8485 (2006
17. Bittencourt, D. et al. G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA 109, 19673-19678 (2012
18. Purcell, D. J., Jeong, K. W., Bittencourt, D., Gerke, D. S., & Stallcup, M. R A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation. J. Biol. Chem. 286, 41963-41971 (2011).
19. Kubicek, S. et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25, 473-481 (2007
20. Tachibana, M. et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19, 815-826 (2005
21. Lee, J. S. et al. Negative regulation of hypoxic responses via induced Reptin methylation. Mol. Cell 39, 71-85 (2010
22. Lee, J. S. et al. Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proc. Natl Acad. Sci. USA 108, 13510-13515 (2011
23. Leutz, A., Pless, O., Lappe, M., Dittmar, G., & Kowenz-Leutz, E. Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs. Transcription 2, 3-8 (2011
24. Rathert, P. et al. Protein lysine methyltransferase G9a acts on non-histone targets. Nat. Chem. Biol. 4, 344-346 (2008
25. Pless, O. et al. G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. J. Biol. Chem. 283, 26357-26363 (2008
26. Conway, K. et al. Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. Breast Cancer Res. 9, R36 (2007
27. Barone, I. et al. Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. Oncogene 29, 2404-2414 (2010
28. Stewart, M. D., Li, J. W., & Wong, J. M. Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol. Cell. Biol. 25, 2525-2538 (2005
29. Vedadi, M. et al A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol. 7, 566-574 (2011
30. Espejo, A., & Bedford, M. T. Protein-domain microarrays. Methods Mol. Biol. 264, 173-181 (2004
31. Cui, G. et al. PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53. Nat. Struct. Mol. Biol. 19, 916-924 (2012
32. Zhang, T. et al. PHF20 regulates NF-kappaB signalling by disrupting recruitment of PP2A to p65. Nat. Commun. 4, 2062 (2013
33. Kim, J. et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7, 397-403 (2006
34. Badeaux, A. I. et al. Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J. Biol. Chem. 287, 429-437 (2012
35. Cai, Y. et al. Subunit composition and substrate specificity of a MOFcontaining histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J. Biol. Chem. 285, 4268-4272 (2010
36. Rea, S., Xouri, G., & Akhtar, A. Males absent on the first (MOF): from flies to humans. Oncogene 26, 5385-5394 (2007
37. Dou, Y. et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121, 873-885 (2005
38. Jeong, K. W. et al. Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat. Struct. Mol. Biol. 18, 1358-1365 (2011
39. Ansari, K. I., Hussain, I., Shrestha, B., Kasiri, S., & Mandal, S. S. HOXC6 is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment. J. Mol. Biol. 411, 334-349 (2011
40. Xu, J., Wu, R. C., & O?Malley, B. W. Normal and cancer-related functions of the p160 steroid receptor co-Activator (SRC) family. Nat. Rev. Cancer 9, 615-630 (2009
41. Shinkai, Y., & Tachibana, M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 25, 781-788 (2011
42. Won Jeong, K., Chodankar, R., Purcell, D. J., Bittencourt, D., & Stallcup, M. R. Gene-specific patterns of coregulator requirements by estrogen receptor-Alpha in breast cancer cells. Mol. Endocrinol. 26, 955-966 (2012
43. Xu, K. et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338, 1465-1469 (2012
44. Ling, B. M. et al. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc. Natl Acad. Sci. USA 109, 841-846 (2012
45. Huang, J. et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285, 9636-9641 (2010
46. Latham, J. A., & Dent, S. Y. Cross-regulation of histone modifications. Nat. Struct. Mol. Biol. 14, 1017-1024 (2007
47. Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol. Cell Biol. 19, 1002-1015 (1999
48. Regnard, C. et al. Global analysis of the relationship between JIL-1 Kinase and Transcription. PLoS Genet. 7, e1001327 (2011
49. Fuqua, S. A. et al A hypersensitive estrogen receptor-Alpha mutation in premalignant breast lesions. Cancer Res. 60, 4026-4029 (2000
50. Tokunaga, E., Kimura, Y., & Maehara, Y. No hypersensitive estrogen receptoralpha mutation (K303R) in Japanese breast carcinomas. Breast Cancer Res. Treat 84, 289-292 (2004
51. Tebbit, C. L., Bentley, R. C., Olson, J. A., & Marks, J. R. Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast. Genes Chromosomes Cancer 40, 51-54 (2004
52. Abbasi, S., Rasouli, M., Nouri, M., & Kalbasi, S. Association of estrogen receptor-Alpha A908G (K303R) mutation with breast cancer risk. Int. J. Clin. Exp. Med. 6, 39-49 (2013
53. Herynk, M. H. et al. Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer. Clin. Cancer Res. 13, 3235-3243 (2007
54. Herynk, M. H. et al. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice. Oncogene 28, 3177-3187 (2009
55. Barone, I. et al. Expression of the K303R estrogen receptor-Alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway. Cancer Res. 69, 4724-4732 (2009
56. Wang, R. A., Mazumdar, A., Vadlamudi, R. K., & Kumar, R. P21-Activated kinase-1 phosphorylates and transactivates estrogen receptor-Alpha and promotes hyperplasia in mammary epithelium. EMBO J. 21, 5437-5447 (2002
57. Berry, N. B., Fan, M., & Nephew, K. P. Estrogen receptor-Alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome. Mol. Endocrinol. 22, 1535-1551 (2008
58. Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M. C., & Corbo, L. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19, 2671-2684 (2005
59. Jenuwein, T., & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001
60. Botuyan, M. V. et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127, 1361-1373 (2006
61. Kachirskaia, I. et al. Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling. J. Biol. Chem. 283, 34660-34666 (2008
62. Tong, Q. et al. Structural plasticity of methyllysine recognition by the tandem Tudor domain of 53BP1. Structure 23, 312-321 (2015
63. Huang, J. et al. p53 is regulated by the lysine demethylase LSD1. Nature 449, 105-108 (2007
64. Saddic, L. A. et al. Methylation of the retinoblastoma tumor suppressor by SMYD2. J. Biol. Chem. 285, 37733-37740 (2010
65. West, L. E. et al. The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression. J. Biol. Chem. 285, 37725-37732 (2010
66. Moore, K. E. et al A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. Mol. Cell 50, 444-456 (2013
67. Liu, F. et al. Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2, 4-diamino-7-Aminoalkoxyquinazolines. J. Med. Chem. 53, 5844-5857 (2010
68. Yuan, Y. et al A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem. Biol. 7, 1152-1157 (2012
69. Klein, B. J. et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 6, 325-335 (2014
70. Akue-Gedu, R. et al. Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors. J. Med. Chem. 52, 6369-6381 (2009
71. Anders, S., Pyl, P. T., & Huber, W. HTSeq-A Python framework to work with high-Throughput sequencing data. Bioinformatics. 31, 166-169 (2015
72. Robinson, M. D., McCarthy, D. J., & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010
73. Howe, E. A., Sinha, R., Schlauch, D., & Quackenbush, J. RNA-Seq analysis in MeV. Bioinformatics 27, 3209-3210 (2011
74. Barr, A. J. et al. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136, 352-363 (2009